Case Studies
Human Heart-Forming Organoid Development
New Approach Methodologies (NAM’s): Emerging Human-Based Disease Models
A Success Story of the RoSS. FILL Automated Filling Solution that Connects Upstream, Downstream and Fill & Finish
Pharmaceutical bioprocessing is still dominated by non-closed, in-house solutions, with high levels of manual intervention that drive process inconsistency and increase the risk of contamination.
Streamline Bioprocessing with Ready-to-Use Buffer Solutions
Rapid growth can bring rapid challenges. When a leading Contract Development and Manufacturing Organization (CDMO) faced an unexpected surge in demand for one of their client’s newly approved therapeutics
When 90% of the world stopped working, we achieved 100% reliability.
Over the last few years, ACG has achieved remarkable things. We have weathered COVID-19 and many other crises. If you’d like to hear how we can help you in good times and bad, please get in touch
The next global supply chain crisis is imminent. and we're already planning for it.
Over the last few years, ACG has achieved remarkable things. We have weathered COVID-19 and many other crises. If you’d like to hear how we can help you in good times and bad, please get in touch.
When 90% of the world stopped working, we achieved 100% reliability.
Over the last few years, ACG has achieved remarkable things. We have weathered COVID-19 and many other crises. If you’d like to hear how we can help you in good times and bad, please get in touch.
We don't know what or when the next global supply crisis will be. That's why we're already planning for it.
Over the last few years we have learnt how to become better prepared to provide reliable service even in the most trying times. If you’d like to hear more about how we can help you, please get in touch.
New Approach Methodologies (NAM’s): Emerging Human-Based Disease Models
Designed to better mimic human biology, NAMs promise improved predictive accuracy for disease models, offering more relevant insights into human health.
Accelerator™ Drug Development: Driving Global Clinical Research Success Through Integrated Governance
Coordinating large-scale clinical research programs across multiple geographies, vendors, and timelines often creates complexity and risk.
Accelerator™ Drug Development: Collaborative Timeline Management Drives Speed and Simplicity in Global Vaccine Trial
Coordinating a global Phase III vaccine study across 6,000+ subjects, 170 sites, and 20+ countries presents extraordinary logistical and regulatory challenges from cold-chain distribution to regional labeling and site activation.
